Tools and Resources

Using New TB Medicines: an E-course for Health Workers

This self-paced course introduces healthcare workers to new TB medicines and new regimens for the treatment of multi-drug resistant TB.

Using New TB Medicines and Regimens

Important Documents

Request technical assistance in meeting WHO conditions for new TB medicine use
GDF Bedaquiline Donation Requirement Form

Obtain the new TB medicines
GDF Bedaquiline Donation Program Direct Procurement Request Form 2015

 

Active Drug Safety Monitoring and Management/Pharmacovigilance

GDF Bedaquiline Donation Program Serious Adverse Event Reporting Form

WHO Active TB drug safety monitoring and management (aDSM) framework for implementation

PViMS

Sample Serious Adverse Event forms:

Clinical and Laboratory Testing Schedule for aDSM

 

WHO Guidelines and Recommendations

Companion handbook to WHO guidelines for programmatic management of DR-TB

WHO_Guidelines for the programmatic management of drug-resistant TB

WHO_Interim policy guidance on the use of Bedaquiline for treatment of DR-TB

WHO_Interim policy guidance on the use of Delamanid for treatment of DR-TB

WHO_The use of bedaquiline in the treatment of MDR-TB_Expert Group Meeting Report

 

Sample Training Materials

These materials can be used as part of a training workshop for clinicians who will treat MDR-TB patients with bedaquiline or delamanid. The modules can be used individually or in combination with additional materials based on each unique setting.

Management of Selected Adverse Events
Outpatient Care and New Drugs
Strategies for Adherence Support
Use of New TB Medicines in Special Populations
Usual AEs DAIDS